ASO Author Reflections: Improving Identification of Intraductal Papillary Mucinous Neoplasm Patients at Risk-Current Status and the Role of IPMN Molecular Biomarkers

Ann Surg Oncol. 2018 Dec;25(Suppl 3):818-819. doi: 10.1245/s10434-018-6901-z. Epub 2018 Oct 11.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adenocarcinoma, Mucinous*
  • Biomarkers
  • Carcinoma, Pancreatic Ductal*
  • Humans
  • Incidence
  • Pancreatic Neoplasms*

Substances

  • Biomarkers